These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 22281205

  • 1. Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism.
    Crane AL, Klein K, Zanger UM, Olson JR.
    Toxicology; 2012 Mar 11; 293(1-3):115-122. PubMed ID: 22281205
    [Abstract] [Full Text] [Related]

  • 2. Bioactivation of chlorpyrifos by CYP2B6 variants.
    Crane AL, Klein K, Olson JR.
    Xenobiotica; 2012 Dec 11; 42(12):1255-62. PubMed ID: 22775490
    [Abstract] [Full Text] [Related]

  • 3. Human variation in CYP-specific chlorpyrifos metabolism.
    Croom EL, Wallace AD, Hodgson E.
    Toxicology; 2010 Oct 29; 276(3):184-91. PubMed ID: 20709133
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC, Wallace AD, Hodgson E, Rose RL.
    Drug Metab Dispos; 2006 Oct 29; 34(10):1779-85. PubMed ID: 16855053
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation.
    Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A.
    Pharmacogenomics J; 2003 Oct 29; 3(1):53-61. PubMed ID: 12629583
    [Abstract] [Full Text] [Related]

  • 10. Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms.
    Lee HK, Moon JK, Chang CH, Choi H, Park HW, Park BS, Lee HS, Hwang EC, Lee YD, Liu KH, Kim JH.
    Drug Metab Dispos; 2006 Jul 29; 34(7):1090-5. PubMed ID: 16581944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.
    Zhang H, Sridar C, Kenaan C, Amunugama H, Ballou DP, Hollenberg PF.
    J Pharmacol Exp Ther; 2011 Sep 29; 338(3):803-9. PubMed ID: 21659470
    [Abstract] [Full Text] [Related]

  • 14. The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation.
    Helsby NA, Hui CY, Goldthorpe MA, Coller JK, Soh MC, Gow PJ, De Zoysa JZ, Tingle MD.
    Br J Clin Pharmacol; 2010 Dec 29; 70(6):844-53. PubMed ID: 21175440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human hepatic cytochrome p450-specific metabolism of parathion and chlorpyrifos.
    Foxenberg RJ, McGarrigle BP, Knaak JB, Kostyniak PJ, Olson JR.
    Drug Metab Dispos; 2007 Feb 29; 35(2):189-93. PubMed ID: 17079358
    [Abstract] [Full Text] [Related]

  • 18. Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.
    Ellison CA, Abou El-Ella SS, Tawfik M, Lein PJ, Olson JR.
    J Toxicol Environ Health A; 2012 Feb 29; 75(4):232-41. PubMed ID: 22352331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.
    Hesse LM, He P, Krishnaswamy S, Hao Q, Hogan K, von Moltke LL, Greenblatt DJ, Court MH.
    Pharmacogenetics; 2004 Apr 29; 14(4):225-38. PubMed ID: 15083067
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.